Type 2 Diabetes Trial, Recruiting (NCT04802395)

Type 2 Diabetes Trial, Recruiting NCT04802395 Sponsor: Renalytix AI, Inc. Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT04802395 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Type 2 diabetes AND also have chronic kidney disease at a specific stage (confirm with trial site for exact staging details)

Who may not be able to join:

Your kidney function levels or protein-in-urine measurements do not fall within the specific ranges required for this trial (confirm with trial site)
Your kidneys are functioning at either too low or too high a level based on a standard kidney function test, unless certain levels of protein are found in your urine (confirm with trial site)
You currently have complete kidney failure or are receiving any treatment to help your kidneys recover
You are currently pregnant
You are currently staying in a hospital
You do not have at least 6 months of relevant medical history on record before the study start date
You are currently taking the medication Enbrel (etanercept)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 646-397-3970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04802395

Sponsor: Renalytix AI, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 646-397-3970

More information: https://clinicaltrials.gov/study/NCT04802395

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Type 2 diabetes AND also have chronic kidney disease at a specific stage (confirm with trial site for exact staging details)

Who may not be able to join:

Your kidney function levels or protein-in-urine measurements do not fall within the specific ranges required for this trial (confirm with trial site)
Your kidneys are functioning at either too low or too high a level based on a standard kidney function test, unless certain levels of protein are found in your urine (confirm with trial site)
You currently have complete kidney failure or are receiving any treatment to help your kidneys recover
You are currently pregnant
You are currently staying in a hospital
You do not have at least 6 months of relevant medical history on record before the study start date
You are currently taking the medication Enbrel (etanercept)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Renalytix AI, Inc.

Registry

ClinicalTrials.gov

Start date

2 March 2021

Est. completion

2 December 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Referrals; Statins and or ACEi/ARB; HbA1c; SGLT2/ GLP1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov